Patent · US Active

Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex

US12344675B2 · kind B2 · utility

0Cited by
67References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2024
Grant dateJul 1, 2025
Priority date—
Expiry dateOct 25, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cancer therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.